These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 11117435)
41. 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease. Yang SY; He XY; Schulz H FEBS J; 2005 Oct; 272(19):4874-83. PubMed ID: 16176262 [TBL] [Abstract][Full Text] [Related]
42. Chemical diagnosis of inherited defects of fatty acid metabolism and ketogenesis. Duran M; Wadman SK Enzyme; 1987; 38(1-4):115-23. PubMed ID: 3326728 [TBL] [Abstract][Full Text] [Related]
43. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies. Gregersen N Scand J Clin Lab Invest Suppl; 1985; 174():1-60. PubMed ID: 3892650 [TBL] [Abstract][Full Text] [Related]
47. Long-chain L-3-hydroxyacyl-coenzyme a dehydrogenase deficiency: a molecular and biochemical review. Rakheja D; Bennett MJ; Rogers BB Lab Invest; 2002 Jul; 82(7):815-24. PubMed ID: 12118083 [TBL] [Abstract][Full Text] [Related]
48. Recent Advances in the Pathophysiology of Fatty Acid Oxidation Defects: Secondary Alterations of Bioenergetics and Mitochondrial Calcium Homeostasis Caused by the Accumulating Fatty Acids. Amaral AU; Wajner M Front Genet; 2020; 11():598976. PubMed ID: 33329744 [TBL] [Abstract][Full Text] [Related]
49. Metabolism of phenolics in coffee and plant-based foods by canonical pathways: an assessment of the role of fatty acid β-oxidation to generate biologically-active and -inactive intermediates. Clifford MN; King LJ; Kerimi A; Pereira-Caro MG; Williamson G Crit Rev Food Sci Nutr; 2024; 64(11):3326-3383. PubMed ID: 36226718 [TBL] [Abstract][Full Text] [Related]
50. 3-Methylglutarylcarnitine: A biomarker of mitochondrial dysfunction. Jennings EA; Abi-Rached ZH; Jones DE; Ryan RO Clin Chim Acta; 2023 Nov; 551():117629. PubMed ID: 37935273 [TBL] [Abstract][Full Text] [Related]
51. Molecular mechanisms of protein induced hyperinsulinaemic hypoglycaemia. Chandran S; Yap F; Hussain K World J Diabetes; 2014 Oct; 5(5):666-77. PubMed ID: 25317244 [TBL] [Abstract][Full Text] [Related]
52. Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers. Fang H; Li H; Zhang H; Wang S; Xu S; Chang L; Yang Y; Cui R Front Pharmacol; 2022; 13():1019312. PubMed ID: 36313354 [TBL] [Abstract][Full Text] [Related]
53. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified. Jones PM; Burlina AB; Bennett MJ J Inherit Metab Dis; 2000 Nov; 23(7):745-50. PubMed ID: 11117435 [TBL] [Abstract][Full Text] [Related]
54. Mitochondrial β-oxidation of saturated fatty acids in humans. Adeva-Andany MM; Carneiro-Freire N; Seco-Filgueira M; Fernández-Fernández C; Mouriño-Bayolo D Mitochondrion; 2019 May; 46():73-90. PubMed ID: 29551309 [TBL] [Abstract][Full Text] [Related]
55. Mouse models for disorders of mitochondrial fatty acid beta-oxidation. Schuler AM; Wood PA ILAR J; 2002; 43(2):57-65. PubMed ID: 11917157 [TBL] [Abstract][Full Text] [Related]
56. Clinical and biochemical features of fatty acid oxidation disorders. Rinaldo P; Raymond K; al-Odaib A; Bennett MJ Curr Opin Pediatr; 1998 Dec; 10(6):615-21. PubMed ID: 9848022 [TBL] [Abstract][Full Text] [Related]